Public Health - Phenibut Consumer Protection Act (JT Alvey Phenibut Consumer Protection Act)

HB 996, the Phenibut Consumer Protection Act, regulates the sale of phenibut products (containing beta-phenyl-gamma-aminobutyric acid HCL) by requiring retailers to disclose factual claims on product labels and prohibiting sales of unsafe or mislabeled products. It bans selling phenibut to anyone under 21, prohibits advertising therapeutic benefits or marketing to minors (including restrictions on cartoons, superheroes, or youth-targeted imagery), and bans products adulterated with dangerous substances. Retailers violating these rules face civil penalties up to $1,000 for labeling issues or criminal fines up to $5,000 for safety or age violations. The bill also mandates the Maryland Department of Health to report on adverse health events linked to phenibut use by the legislature.